Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
06/1998
06/10/1998EP0846704A2 Highly fermentable resistant starch
06/10/1998EP0846694A1 Morphinan derivative and its pharmaceutical applications
06/10/1998EP0846687A1 Pyrazoles as human non-pancreatic secretory phospholipase A2 inhibitors
06/10/1998EP0846464A2 Use of glycogen phosphorylase inhibitor for reducing non-cardiac tissue damage resulting from ischemia
06/10/1998EP0846422A1 Anti-regurgitation infant formula
06/10/1998EP0846116A1 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists
06/10/1998EP0846108A1 Amino-substituted thiadiazoles, pyrimidines, triazines or triazoles useful as ctf receptor antagonists
06/10/1998EP0845987A1 C-proteinase inhibitors for the treatment of disorders related to the overproduction of collagen
06/10/1998CN1184470A Thienyl-, Furyl-, Pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
06/10/1998CN1184469A 1 -phenylpyrazole-3 -carboxamides acting on neurotensin receptors
06/10/1998CN1184421A Treatment of inflammatory bowel disease using oral dosage forms of omega -3 polyunsaturated acids
06/10/1998CN1183981A Chinese medicine for gastropathy related to pyloric spiri-bacillus
06/10/1998CN1038680C Dihydronaphtho £1, 2-b| pyrane derivative and its producing process and use
06/09/1998US5763621 Reaction of acid compound with hydroxylamine compound or amidation of acid
06/09/1998US5763567 Human amino acid sequences which can bind to and/or neutralize heparin
06/09/1998US5763458 1-phenylalkanone 5-HT4 receptor ligands
06/09/1998US5763437 Benzodiazepine derivatives
06/09/1998US5763435 Administering to mammal to treat liver disease or inflammatory condition of gastrointestinal tract
06/09/1998US5763433 Pharmaceutical compositions containing 3-beta-hydroxylated 6,7-substituted steroid derivatives, and use thereof
06/09/1998US5763247 Nucleotide fragments and uses thereof for obtaining bactericide-producing compositions
06/09/1998US5763246 DNA encoding arginyl tRNA synthetase from staphylococcus aureus
06/09/1998US5763220 Human apoptosis-related calcium-binding protein
06/09/1998US5762922 Antioxidants and intracellular gluthathione raising agents for therapeutic treatments
06/09/1998US5762911 Anti-caries oral compositions
06/09/1998CA2111223C Benzo- and pyridopyran derivatives having anxiolytic and anti-convulsant activity
06/09/1998CA2040011C Thiazole and imidazole derivatives and antiulcer composition containing same
06/05/1998CA2223317A1 Method of reducing tissue damage associated with non-cardiac ischemia using glycogen phosphorylase inhibitors
06/04/1998WO1998023611A1 2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists
06/04/1998WO1998023610A1 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists
06/04/1998WO1998023609A1 2-imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists
06/04/1998WO1998023596A1 Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists
06/04/1998WO1998023591A1 Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
06/04/1998WO1998023575A1 Asiatic acid derivatives having modified a-ring
06/04/1998WO1998023273A1 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators
06/04/1998WO1998023272A1 Compositions and methods for the treatment of gastrointestinal disorders
06/04/1998WO1998009599A3 The new use of dicaffeoylquinic acid for treating hepatitis b and the diseases related with retrovirus, and the new caffeoylquinic acid derivatives
06/04/1998CA2272683A1 2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists
06/04/1998CA2272644A1 2-imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists
06/04/1998CA2266605A1 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators
06/03/1998EP0844881A1 Combination osmotic and bulk forming laxatives
06/03/1998EP0844875A2 Use of basic amino acids and derivatives for lowering ceramide levels
06/03/1998EP0683767B1 Azacyclic compounds, compositions containing them and their use as tachykinin antagonists
06/03/1998CN1183786A Bicyclic tachykinins antagonists, preparation thereof and their use in autagonistes composition
06/03/1998CN1183765A Phenoxyethyamine derivs. having high affinity for 5 -HT1A receptor, preparation thereof, use thereof as drugs, and pharmaceutical composition contg. said derivs
06/03/1998CN1183726A Synthetic cryptophycins
06/03/1998CN1183724A Laryngeal bactericidal and antiseptic composition
06/03/1998CN1183717A Use of R-NSAID in protective composition for treatment of colorectal cancer
06/03/1998CN1183413A Thiazolidine derivative and its use for making medicanients
06/03/1998CN1183293A 蒲元胃康 Puyuanweikang
06/03/1998CN1183282A Oral liquid for strengthening liver and preparaing process thereof
06/03/1998CN1183276A Pharmaceutical compositions containing thiazolidine derivative and preparation process thereof
06/03/1998CN1183275A Use of thiazolidine derivative for making medicaments
06/03/1998CN1038586C Process for preparing pyrazine derivs
06/03/1998CA2223149A1 Highly fermentable resistant starch
06/02/1998US5760248 Having improved metabolic stability
06/02/1998US5760086 Nasal administration of agents for treatment of delayed onset emesis
06/02/1998US5760051 Central nervous system
06/02/1998US5760035 Piperidine compounds substituted with an aminoalkyl group and an aryloxyalkyl group, antiallergens, antiinflammatory agents, immunosuppressants
06/02/1998US5760018 Treatment of pain, inflammation, migraine, emesis
06/02/1998US5759548 Using plant extract
06/02/1998CA2012278C Mutant of microbacterium, a strain 851r, and a process for producing 851r nutrient solution by application of the strain
05/1998
05/28/1998WO1998022492A1 Nucleotide and protein sequences of liver activin/inhibin and methods based thereon
05/28/1998WO1998022465A1 A1 adenosine receptor antagonists
05/28/1998WO1998022464A1 Xanthines and their therapeutic use
05/28/1998WO1998022460A1 Bicyclic aryl carboxamides and their therapeutic use
05/28/1998WO1998022457A1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
05/28/1998WO1998022436A1 Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors
05/28/1998WO1998022111A1 Anti-helicobacter pylori drugs
05/28/1998WO1998022101A2 Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents
05/28/1998WO1998022079A1 Dentifrice compositions containing polyphosphate and fluoride
05/28/1998WO1998021957A1 Triaryl substituted imidazoles, compositions containing such compounds and methods of use
05/28/1998WO1998016503A3 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
05/28/1998WO1998016184A3 Purine l-nucleosides, analogs and uses thereof
05/28/1998DE19646782A1 Bioresorbierbare Polymerisationsprodukte aus strahlungshärtbaren Bindemittelsystemen Bioabsorbable polymerization of radiation-curable binder systems
05/28/1998CA2272545A1 Nucleotide and protein sequences of liver activin/inhibin and methods based thereon
05/28/1998CA2271963A1 Triaryl substituted imidazoles, compositions containing such compounds and methods of use
05/28/1998CA2271767A1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
05/28/1998CA2268770A1 Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors
05/28/1998CA2268041A1 Xanthines and their therapeutic use
05/28/1998CA2268037A1 Bicyclic aryl carboxamides and their therapeutic use
05/27/1998EP0843681A1 Heterocycle-fused thiazole derivatives
05/27/1998EP0843677A1 4-amino-3-acylnaphthyridine derivatives
05/27/1998EP0843556A1 Glyceryl poly(meth)acrylate type gel based pharmaceutical compositions
05/27/1998EP0843549A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a 4? hydrolase inhibitor
05/27/1998EP0587571B1 HUMAN GALANIN, cDNA CLONES ENCODING HUMAN GALANIN AND A METHOD OF PRODUCING HUMAN GALANIN
05/27/1998CN1183096A Optically active thiazolidinone derivatives
05/27/1998CN1183049A Oral Pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent
05/27/1998CN1183047A Oral Pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate
05/27/1998CN1183041A Indazolecarboxamides
05/27/1998CN1182611A Traditional Chinese powder medicine for hepatosis
05/27/1998CN1182609A Weikang capsule for curing gastric disease
05/27/1998CN1038505C Trifluoromethyl mercaptan and mercaptoacyl derivatives and method of using same
05/26/1998US5756669 Mutants
05/26/1998US5756668 Hypermethylated in cancer polypeptide, HIC-1
05/26/1998US5756665 Signal peptide which initiates expression of a bactericide composition
05/26/1998US5756505 N-acylpiperazine derivative, antibacterial drug and anti-ulcer drug
05/26/1998US5756503 Analgesics, anesthetics, antiinflammatory agents
05/26/1998US5756499 Substituted imidazole compounds
05/26/1998US5756084 Human stromal derived factor 1α and 1β
05/26/1998CA2057053C Recombinant alzheimer's amyloid protein
1 ... 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 ... 1258